Zobrazeno 1 - 10
of 292
pro vyhledávání: '"Daniel Taussky"'
Autor:
Johanna Dahan, Jehonathan Pinthus, Guila Delouya, Daniel Taussky, Emmanuelle Duceppe, Amanda de Jesus, Darryl Leong
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Introduction Several blood markers of inflammation are elevated in prostate cancer (PCa) and have prognostic value. Little is known about the relationship between these markers, PCa, and other factors associated with chronic inflammation, su
Externí odkaz:
https://doaj.org/article/4a1cf0e8f74c417d8351a46ccc5924ab
Autor:
Matthieu Vermeille, Kira-Lee Koster, David Benzaquen, Ambroise Champion, Daniel Taussky, Kevin Kaulanjan, Martin Früh
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9886-9894 (2023)
Background: Despite recent awareness of institutional racism, there are still important racial disparities in prostate cancer medical research. We investigated the historical development of research on racial disparities and bias. Methods: PubMed was
Externí odkaz:
https://doaj.org/article/86620ec0d5db411a8dbc9e3a969d6927
Autor:
Ambroise Champion, Daniel Rudolf Zwhalen, Christoph Oehler, Daniel Taussky, Stephanie G. C. Kroeze, Irene A. Burger, David Benzaquen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
There are few randomized trials to evaluate the use of PSMA-PET in the planning of post-prostatectomy radiotherapy. There are two unresolved questions 1) should we increase the dose to lesions visible on PSMA-PET 2) can we reduce dose in the case of
Externí odkaz:
https://doaj.org/article/bb2c45dce2ee4248811083c09dd966be
Publikováno v:
Urology Case Reports, Vol 50, Iss , Pp 102538- (2023)
We present a case of a patient with recurrent prostate cancer after treatment for favorable intermediate risk cancer. There was an exceptionally steep increase in PSA from
Externí odkaz:
https://doaj.org/article/fce2e90a6aac425297047f2ccb03cf0d
Autor:
Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu (Amy) Liu, Lisa Joseph, Maroie Barkati, Alejandro Berlin, Guila Delouya, Daniel Taussky, Marie-Claude Beauchemin, Benedicte Nicolas, Samuel Kadoury, Alexandra Rink, Srinivas Raman, Aravindhan Sundaramurthy, Robert Weersink, Dominic Beliveau-Nadeau, Joelle Helou, Peter Chung
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/1ed7fd47aaee4999b532ace495cf38de
Autor:
Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu (Amy) Liu, Lisa Joseph, Maroie Barkati, Alejandro Berlin, Guila Delouya, Daniel Taussky, Marie-Claude Beauchemin, Benedicte Nicolas, Samuel Kadoury, Alexandra Rink, Srinivas Raman, Aravindhan Sundaramurthy, Robert Weersink, Dominic Beliveau-Nadeau, Joelle Helou, Peter Chung
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and purposeLocally recurrent prostate cancer after radiotherapy merits an effective salvage strategy that mitigates the risk of adverse events. We report outcomes of a cohort enrolled across two institutions investigating MRI-guided tumor-
Externí odkaz:
https://doaj.org/article/fb4ebd5427f24fa58d553b0cc2684064
Autor:
Leah Taussky, Sabrina Harmouch, MD, BSc, Guila Delouya, MD, MSc, Carole Lambert, MD, MSc, Jean-Paul Bahary, MD, MSc, Louise Lambert, MD, Laura Masucci, MD, Normand Blais, MD, An Tang, MD, MSc, Daniel Liberman, MD, Kevin C. Zorn, MD, Daniel Taussky, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 313-317 (2020)
Purpose: The progress of women in academic medicine appears to be curtailed. We evaluated gender differences in academia for residents in radiation oncology compared with 2 of its related specialties, radiology and medical oncology, across Canada. Me
Externí odkaz:
https://doaj.org/article/fc86822a199b4deaa0ec664c6549de64
Autor:
Lara Hathout, MD, FRCPC, Omar Mahmoud, MD, PhD, Yaqun Wang, PhD, Irina Vergalasova, PhD, Maroie Barkati, MD, FRCPC, Philippe Després, PhD, André-Guy Martin, MD, MSc, FRCPC, William Foster, MD, FRCPC, Frédéric Lacroix, PhD, Guila Delouya, MD, MSc, FRCPC, Daniel Taussky, MD, FRCPC, Gerard Morton, MD, FRCPC, Eric Vigneault, MD, MSc, FRCPC
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 631-640 (2019)
Purpose: To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi-institutional phase 2 randomized trial. Methods and Materials: Men wi
Externí odkaz:
https://doaj.org/article/05bb84c95123416c9cb0633640430fe4
Autor:
Vincent Q. Trinh, Nazim Benzerdjeb, Ségolène Chagnon-Monarque, Nicolas Dionne, Guila Delouya, André Kougioumoutzakis, Jennifer Sirois, Roula Albadine, Mathieu Latour, Anne-Marie Mes-Masson, Hélène Hovington, Alain Bergeron, Kevin C. Zorn, Yves Fradet, Fred Saad, Daniel Taussky, Dominique Trudel
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of recurrence and survival with particular treatment response, yet no study has tested its response to radiotherapy. The aim of our project was to test the
Externí odkaz:
https://doaj.org/article/99a668a744c641e5b96067b06bed853e
Publikováno v:
Brachytherapy. 21:864-869
Neutrophil-to-lymphocyte ratio (NLR), a marker for subclinical inflammation, has been previously shown to be associated with erectile dysfunction (ED). We studied the potential predictive value of the NLR on ED after prostate brachytherapy (PB) for P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a22765fe70874ff2e07700f0daff8a
https://doi.org/10.1016/j.brachy.2022.02.001
https://doi.org/10.1016/j.brachy.2022.02.001